Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Clinical Pharmacokinetics

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40262-017-0588-3PMID 28905331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumannii.

  2017cited by this paper
• Characteristics of infarction after encephaloduroarteriosynangiosis in young patients with moyamoya disease.

  2017cited by this paper
• 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.

  2017cited by this paper
• Penetration of Vancomycin into the Cerebrospinal Fluid: A Systematic Review

  2017cited by this paper
• Augmented Renal Clearance in Traumatic Brain Injury: A Single-Center Observational Study of Atrial Natriuretic Peptide, Cardiac Output, and Creatinine Clearance

  2017cited by this paper
• Management of infections associated with neurosurgical implanted devices

  2017cited by this paper
• General Concepts of Pharmacodynamics for Anti-infective Agents

  2016cited by this paper
• Pharmacodynamics of Daptomycin

  2016cited by this paper
• Clinical and Laboratory Characteristics for the Diagnosis of Bacterial Ventriculitis After Aneurysmal Subarachnoid Hemorrhage

  2016cited by this paper
• Pharmacokinetic and pharmacodynamic principles of antimicrobials

  2016cited by this paper
• A case of meningococcal meningitis that was difficult to treat owing to concurrent ventriculitis.

  2016cited by this paper
• Clinical Characteristics and Predictors of Adverse Outcome in Adult and Pediatric Patients With Healthcare-Associated Ventriculitis and Meningitis

  2016cited by this paper
• Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study

  2016cited by this paper
• Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients.

  2015cited by this paper
• No additional protection against ventriculitis with prolonged systemic antibiotic prophylaxis for patients treated with antibiotic-coated external ventricular drains.

  2015cited by this paper
• A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections

  2015cited by this paper
• Does Critical Illness Change Levofloxacin Pharmacokinetics?

  2015cited by this paper
• Pharmacokinetics and preliminary safety of high dose linezolid for the treatment of Gram-positive bacterial infections.

  2015cited by this paper
• Clinical, biological, and microbiological pattern associated with ventriculostomy-related infection: a retrospective longitudinal study

  2015cited by this paper
• External Ventricular and Lumbar Drain Device Infections in ICU Patients: A Prospective Multicenter Italian Study

  2015cited by this paper
• Options for treating carbapenem-resistant Enterobacteriaceae

  2014cited by this paper
• Systematic Review of Efficacy, Pharmacokinetics, and Administration of Intraventricular Aminoglycosides in Adults

  2014cited by this paper
• Combination therapy for carbapenem-resistant Gram-negative bacteria.

  2014cited by this paper
• Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study

  2014cited by this paper
• Augmented Renal Clearance in the ICU: Results of a Multicenter Observational Study of Renal Function in Critically Ill Patients With Normal Plasma Creatinine Concentrations*

  2014cited by this paper
• Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.

  2014cited by this paper
• Ventriculostomy-Associated Infection: A New, Standardized Reporting Definition and Institutional Experience

  2014cited by this paper
• Risk factors for infection with multidrug-resistant bacteria in non-ventilated patients with hospital-acquired pneumonia,

  2013cited by this paper
• Risk Factors for a Low Linezolid Trough Plasma Concentration in Acute Infections

  2013cited by this paper
• DrugBank 4.0: shedding new light on drug metabolism

  2013cited by this paper
• Characteristics of infections associated with external ventricular drains of cerebrospinal fluid.

  2013cited by this paper
• Salmonella enteritidis ventriculitis.

  2013cited by this paper
• Diagnosis of ventilator-associated pneumonia: controversies and working toward a gold standard

  2013cited by this paper
• Systematic Review of Efficacy, Pharmacokinetics, and Administration of Intraventricular Vancomycin in Adults

  2012cited by this paper
• Intraventricular Daptomycin and Intravenous Linezolid for the Treatment of External Ventricular-Drain–Associated Ventriculitis Due to Vancomycin-Resistant Enterococcus faecium

  2012cited by this paper
• Pharmacokinetics of Colistin in Cerebrospinal Fluid after Intraventricular Administration of Colistin Methanesulfonate

  2012cited by this paper
• The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients

  2011cited by this paper
• Blood–Brain Barrier Pathophysiology in Traumatic Brain Injury

  2011cited by this paper
• Cerebrospinal fluid diversion devices and infection. A comprehensive review

  2011cited by this paper
• Pharmacokinetics-Pharmacodynamics of Tigecycline in Patients with Community-Acquired Pneumonia

  2011cited by this paper
• Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

  2011cited by this paper
• Pharmacokinetics of Single-Dose Daptomycin in Patients with Suspected or Confirmed Neurological Infections

  2011cited by this paper
• Implications of augmented renal clearance in critically ill patients

  2011cited by this paper
• Low Tigecycline Concentrations in the Cerebrospinal Fluid of a Neutropenic Patient with Inflamed Meninges

  2010cited by this paper
• Serum and Cerebrospinal Fluid Levels of Colistin in Pediatric Patients

  2010cited by this paper
• Pharmacokinetics of linezolid in septic patients with and without extended dialysis

  2010cited by this paper
• Cerebrospinal Fluid Penetration of High-Dose Daptomycin in Suspected Staphylococcus aureus Meningitis

  2010cited by this paper
• Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections

  2010cited by this paper
• Improving the role of intraventricular antimicrobial agents in the management of meningitis

  2009cited by this paper
• LC Method for the Determination of Meropenem in Cerebrospinal Fluid: Application to Therapeutic Drug Monitoring

  2009cited by this paper
• Regulation of BCRP (ABCG2) and P-Glycoprotein (ABCB1) by Cytokines in a Model of the Human Blood–Brain Barrier

  2009cited by this paper
• Protein binding of ampicillin. Path analysis of a twin material.

  2009cited by this paper
• Brain injury-associated biomarkers of TGF-beta1, S100B, GFAP, NF-L, tTG, AbetaPP, and tau were concomitantly enhanced and the UPS was impaired during acute brain injury caused by Toxocara canis in mice

  2008cited by this paper
• Brain endothelial cells and the glio-vascular complex

  2008cited by this paper
• Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.

  2008cited by this paper
• Population Pharmacokinetics of Levofloxacin, Gatifloxacin, and Moxifloxacin in Adults with Pulmonary Tuberculosis

  2007cited by this paper
• Quantification of meropenem in plasma and cerebrospinal fluid by micellar electrokinetic capillary chromatography and application in bacterial meningitis patients.

  2007cited by this paper
• Population Pharmacokinetics of Tigecycline in Healthy Volunteers

  2007cited by this paper
• Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence.

  2007cited by this paper
• Antibiotic management of suspected nosocomial ICU-acquired infection: Does prolonged empiric therapy improve outcome?

  2007cited by this paper
• Pharmacokinetics, cerebrospinal fluid concentration, and safety of intravenous rifampin in pediatric patients undergoing shunt placements

  2006cited by this paper
• The pharmacokinetic and pharmacodynamic properties of vancomycin.

  2006cited by this paper
• Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose.

  2006cited by this paper
• Pharmacodynamic profiling of cefepime in plasma and cerebrospinal fluid of hospitalized patients with external ventriculostomies.

  2006cited by this paper
• A Review of New Fluoroquinolones

  2006cited by this paper
• Practice guidelines for the management of bacterial meningitis.

  2004cited by this paper
• Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis.

  2004cited by this paper
• Gentamicin and tobramycin binding to human serum in vitro.

  2004cited by this paper
• Risk of Infection with Prolonged Ventricular Catheterization

  2004cited by this paper
• Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid.

  2003cited by this paper
• Levofloxacin Disposition in Cerebrospinal Fluid in Patients with External Ventriculostomy

  2003cited by this paper
• Cefepime: a review of its use in the management of hospitalized patients with pneumonia.

  2003cited by this paper
• Clinical Pharmacodynamics of Linezolid in Seriously Ill Patients Treated in a Compassionate Use Programme

  2003cited by this paper
• Enterobacter cloacae Ventriculitis Successfully Treated with Cefepime and Gentamicin: Case Report and Review of the Literature

  2003cited by this paper
• VENTRICULOSTOMY‐RELATED INFECTIONS: A CRITICAL REVIEW OF THE LITERATURE

  2002cited by this paper
• Cerebrospinal Fluid Penetration and Pharmacokinetic/Pharmacodynamic Parameters of Intravenously Administered Colistin in a Case of Multidrug-Resistant Acinetobacter baumannii Meningitis

  2002cited by this paper
• In Vivo Pharmacodynamics of a New Oxazolidinone (Linezolid)

  2002cited by this paper
• Increasing prevalence of antimicrobial resistance in intensive care units

  2001cited by this paper
• Cerebrospinal fluid penetration of high doses of intravenous ciprofloxacin in meningitis.

  2000cited by this paper
• Pharmacokinetics and pharmacodynamics of antibiotics in meningitis.

  1999cited by this paper
• Pharmacokinetics of Meropenem in Critically Ill Patients with Acute Renal Failure Treated by Continuous Hemodiafiltration

  1998cited by this paper
• Disposition and Elimination of Meropenem in Cerebrospinal Fluid of Hydrocephalic Patients with External Ventriculostomy

  1998cited by this paper
• Antibiotic pharmacodynamics in cerebrospinal fluid.

  1998cited by this paper
• Treatment of bacterial meningitis.

  1997cited by this paper
• Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis

  1997cited by this paper
• Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis

  1995cited by this paper
• Ventriculostomy and intracranial pressure monitoring: in search of a 0% infection rate.

  1995cited by this paper
• Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges.

  1994cited by this paper
• Netilmicin cerebrospinal fluid concentrations after an intravenous infusion of 400 mg in patients without meningeal inflammation.

  1993cited by this paper
• Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis.

  1993cited by this paper
• Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges

  1993cited by this paper
• Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges.

  1992cited by this paper
• The Pennsylvania State University College of Medicine 1991 Bernard B. Brodie Lecture. Insights into deuterium isotope effects on the metabolism of steroid hormones and foreign compounds by cytochrome P-450 enzymes.

  1991cited by this paper
• Penetration of ciprofloxacin into human cerebrospinal fluid in patients with inflamed and non-inflamed meninges

  1991cited by this paper
• Amikacin serum protein binding in spinal cord injury.

  1991cited by this paper
• Penetration of newer cephalosporins into cerebrospinal fluid.

  1989cited by this paper
• Penetration of fosfomycin into cerebrospinal fluid across non-inflamed and inflamed meninges

  1987cited by this paper
• Ventriculostomy-Related Infections

  1984cited by this paper
• Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae.

  1984cited by this paper
• Ventriculostomy-related infections. A prospective epidemiologic study.

  1984cited by this paper

• Assessment of Vancomycin Penetration into Cerebrospinal Fluid in Patients with Ventriculitis Using a Physiologically Based Pharmacokinetic Approach.

  2026cites this paper
• The comparison of three regimens of polymyxin B for the treatment of central nervous system infections caused by carbapenem-resistant bacteria: A retrospective cohort study.

  2025cites this paper
• A systematic review of reviews on ventriculostomy related infection definitions: A fundamental problem

  2025influential citation
• Ceftriaxone population pharmacokinetics in plasma and cerebrospinal fluid of neurocritical care patients.

  2025cites this paper
• Population pharmacokinetics of piperacillin-tazobactam in the plasma and cerebrospinal fluid of critically ill patients

  2024cites this paper
• Treatment optimization by monitoring vancomycin concentration in the serum and cerebrospinal fluid in a child with cystoperitoneal shunt-related infection caused by methicillin-resistant Staphylococcus aureus: a case report and literature review

  2023cites this paper
• Treatment Optimization by Monitoring Vancomycin Concentration in the Serum and Cerebrospinal Fluid in a Child with Cystoperitoneal Shunt-related Infection Caused by Methicillin-resistant Staphylococcus aureus: A case report

  2023cites this paper
• Current Perspectives on the Diagnosis and Management of Healthcare-Associated Ventriculitis and Meningitis

  2022cites this paper
• Efficacy of Vancomycin and Meropenem in Central Nervous System Infections in Children and Adults: Current Update

  2022cites this paper
• Augmented Renal Clearance in Severe Infections—An Important Consideration in Vancomycin Dosing: A Narrative Review

  2022cites this paper
• Effectiveness of interventions to reduce ventriculostomy-associated infections in adult and paediatric patients with an external ventricular drain: A systematic review.

  2022cites this paper
• Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Meropenem in Neurocritical Care Patients: a Prospective Two-Center Study

  2022cites this paper
• The use of intraventricular instillation of vancomycin to prevent external ventricular drainage related infection: clinical prospective study.

  2022cites this paper
• The Blood–Brain Barrier and Pharmacokinetic/Pharmacodynamic Optimization of Antibiotics for the Treatment of Central Nervous System Infections in Adults

  2022cites this paper
• Ventriculitis: Infection or Inflammation

  2021cites this paper
• Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion

  2021influential citation
• Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future

  2021cites this paper
• Staphylococcus haemolyticus meningitis and bacteremia in an allogenic stem cell transplant patient

  2021cites this paper
• Dose optimisation of antibiotics used for meningitis

  2021cites this paper
• Bacterial external ventricular catheter-associated infection

  2020influential citation
• The role of antibiotic pharmacokinetic studies performed post-licensing.

  2020cites this paper
• Clinical Pharmacy Considerations in ICU

  2019cites this paper
• Local complications of adjunct intrathecal antibiotics for nosocomial meningitis associated with gram-negative pathogens: a meta-analysis

  2019cites this paper
• Antibiotic exposure at the site of infection: principles and assessment of tissue penetration

  2019cites this paper
• CSF penetration of vancomycin in critical care patients with proven or suspected ventriculitis: a prospective observational study

  2019cites this paper
• How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients

  2018cites this paper
• High-Dosage Cefazolin Achieves Sufficient Cerebrospinal Diffusion To Treat an External Ventricular Drainage-Related Staphylococcus aureus Ventriculitis

  2018cites this paper
• Expert Consensus on Precision Medicine by Surgical Pharmacists for Oncology in the Perioperative Period

  year unknowncites this paper